Every Spin-Off
OneSource Specialty Pharma
ONESOURCE INCompletedINManufactures drugs under contract for pharmaceutical companies from plants in Bengaluru, India, specialising in biologics, sterile injectables, soft-gel capsules and drug-device combinations such as injection pens.
Strides demerged its specialty pharma CDMO business into OneSource Specialty Pharma (formerly Stelis Biopharma), giving shareholders one OneSource share for every two Strides shares, with listing on NSE and BSE.
- Distribution date
- 24 Jan 2025
- Structure
- Spin-off
- Parent
- Strides Pharma Science (STAR IN)
- Spin-off ticker
- ONESOURCE IN
- Listing
- NSE and BSE
- Market
- India
- Sector
- Health care
- Size
- mid
Source documents
- Press releaseOneSource set to debut on Jan 24 (01/23/25)
- PresentationNot located
- Prospectus / demerger documentNot located
- Sourcebarandbench.com
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email